HNPCC MASTR Plus new product release

HNPCC MASTR Plus new product release

Anatomy - Pathology / Molecular Diagnostics

April 22, 2015

Multiplicom is pleased to announce the release of the new updated HNPCC MASTR™ Plus molecular assay, research use only, for identification of all mutations in the coding region of MLH1, MSH2, MSH6, PMS2 and 3’ UTR of EPCAM genes.

Below is a recapture of the improvements made within this new version:

-          Coverage of MSH6 exon 1

-          100% specificity of PMS2 exon 5

-          Greater MSH2 coverage:

                    o   Detection of splice mutation Exon 5: c.932+3A>T

                    o   Normalize variant allele frequency of Exon 1: rs2303426

-          Addition of CNV mutation analysis

-          Two additional amplicons in the EPCAM region for greater detection of any deletions in the area

Enrich and detect CTCs of prostate cancer from blood

Enrich and detect CTCs of prostate cancer from blood

Anatomy - Pathology / Molecular Diagnostics

Circulating tumor cells (CTCs) constitute a useful approach for personalized medicine. In prostate cancer, the expression of three tumor-associated transcripts, prostate-specific membrane antigen (PSMA), prostate-specific antigen (PSA) and epidermal growth factor receptor (EGFR), are often altered and used as biomarkers.

March 01, 2017 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us